1.13% 0.13

Neogenomics Inc (NEO)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché NEO Giù? Forum Previsione Frazionamento azionario

Neogenomics Inc Azioni (NEO) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	7.91% 181.33	168.03	172.00	167.82	164.50
Cost Of Revenue	9.79% 104.07	94.79	94.74	92.94	92.01
Gross Profit	5.48% 77.26	73.25	77.26	74.88	72.49
Operating Expenses	23.56% 124.89	101.07	95.66	96.08	94.44
Benefits Costs and Expenses	17.27% 227.15	193.69	188.13	185.67	183.52
Costs And Expenses	17.27% 227.15	193.69	188.13	185.67	183.52
Operating Income/Loss	71.17% -47.63	-27.82	-18.40	-21.20	-21.94
Income/Loss From Continuing Operations Before Tax	78.57% -45.82	-25.66	-16.13	-17.85	-19.02
Income Tax Expense/Benefit	372.18% -0.724	0.266	-0.804	-0.15	-0.375
Income/Loss From Continuing Operations After Tax	73.95% -45.09	-25.92	-15.32	-17.70	-18.64
Net Income/Loss	73.95% -45.09	-25.92	-15.32	-17.70	-18.64
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.45% 127.95	127.38	0.167	126.95	126.41
Diluted Average Shares	0.45% 127.95	127.38	0.167	126.95	126.41
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

DGX

$190.58

0.35%

$265.31

0.12%

WAT

$399.54

1.41%

MTD

$1,470.14

1.22%

NTRA

$238.58

3.45%

IQV

$228.18

1.46%